Gene Signature For Predicting Prognosis Of Patients With Solid Tumors


Ontology type: sgo:Patent     


Patent Info

DATE

2014-08-07T00:00

AUTHORS

Xin Wei Wang , Stephanie K. Roessler

ABSTRACT

Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2620", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Xin Wei Wang", 
        "type": "Person"
      }, 
      {
        "name": "Stephanie K. Roessler", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000072654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012895947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3301923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043735865", 
          "https://doi.org/10.1038/sj.gt.3301923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3301923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043735865", 
          "https://doi.org/10.1038/sj.gt.3301923"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08-07T00:00", 
    "description": "

Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described.

", "id": "sg:patent.US-20140220043-A1", "keywords": [ "gene signature", "survival", "patient", "solid tumor", "hepatocellular carcinoma", "Breast Neoplasm", "associated gene", "DLC1", "decrease", "DNA copy number", "mRNA expression", "poor prognosis", "good prognosis", "Predicting", "prognosis", "expression", "method", "agent" ], "name": "GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.27235.31", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-20140220043-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:13", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00817.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20140220043-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

54 TRIPLES      15 PREDICATES      35 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20140220043-A1 schema:about anzsrc-for:2620
2 anzsrc-for:3142
3 schema:author N2443a6e8d8624f2d94962b614387814a
4 schema:citation sg:pub.10.1038/sj.gt.3301923
5 https://doi.org/10.1159/000072654
6 schema:datePublished 2014-08-07T00:00
7 schema:description <p id="p-0001" num="0000">Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described.</p>
8 schema:keywords Breast Neoplasm
9 DLC1
10 DNA copy number
11 Predicting
12 agent
13 associated gene
14 decrease
15 expression
16 gene signature
17 good prognosis
18 hepatocellular carcinoma
19 mRNA expression
20 method
21 patient
22 poor prognosis
23 prognosis
24 solid tumor
25 survival
26 schema:name GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS
27 schema:recipient https://www.grid.ac/institutes/grid.27235.31
28 schema:sameAs https://app.dimensions.ai/details/patent/US-20140220043-A1
29 schema:sdDatePublished 2019-04-18T10:13
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher Nb417ead820844a6ea1da68967157e733
32 sgo:license sg:explorer/license/
33 sgo:sdDataset patents
34 rdf:type sgo:Patent
35 N2443a6e8d8624f2d94962b614387814a rdf:first Nf4f7ea528ff44830ac7ab8923cee58b5
36 rdf:rest Na8053ed9128140699f218e3a21ddd0f2
37 N6e191e1088b8413cb183a575ef3392d0 schema:name Stephanie K. Roessler
38 rdf:type schema:Person
39 Na8053ed9128140699f218e3a21ddd0f2 rdf:first N6e191e1088b8413cb183a575ef3392d0
40 rdf:rest rdf:nil
41 Nb417ead820844a6ea1da68967157e733 schema:name Springer Nature - SN SciGraph project
42 rdf:type schema:Organization
43 Nf4f7ea528ff44830ac7ab8923cee58b5 schema:name Xin Wei Wang
44 rdf:type schema:Person
45 anzsrc-for:2620 schema:inDefinedTermSet anzsrc-for:
46 rdf:type schema:DefinedTerm
47 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
48 rdf:type schema:DefinedTerm
49 sg:pub.10.1038/sj.gt.3301923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043735865
50 https://doi.org/10.1038/sj.gt.3301923
51 rdf:type schema:CreativeWork
52 https://doi.org/10.1159/000072654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012895947
53 rdf:type schema:CreativeWork
54 https://www.grid.ac/institutes/grid.27235.31 schema:Organization
 




Preview window. Press ESC to close (or click here)


...